Use of B-type natriuretic peptide in the management of hypoxaemic respiratory failure.
Noveanu
Markus
M
Department of Internal Medicine, University Hospital Basel, Petersgraben 4, CH-4031Basel, Switzerland.
Pargger
Hans
H
Breidthardt
Tobias
T
Reichlin
Tobias
T
Schindler
Christian
C
Heise
Antje
A
Schoenenberger
Ronald
R
Manndorff
Patricia
P
Siegemund
Martin
M
Mebazaa
Alexandre
A
Marsch
Stephan
S
Mueller
Christian
C
D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000097:blood* / Q000175:diagnosis* / Q000628:therapy; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D011379:Prognosis; D011446:Prospective Studies; D012016:Reference Values; D012131:Respiratory Insufficiency / Q000097:blood* / Q000175:diagnosis* / Q000628:therapy; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D016037:Single-Blind Method; D018709:Statistics, Nonparametric; D013557:Switzerland
D015415:Biomarkers; D020097:Natriuretic Peptide, Brain